Premium
Botox for the prophylaxis of headaches in chronic migraine
Author(s) -
Chaplin Steve,
MacGregor Anne
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.820
Subject(s) - medicine , headaches , migraine , chronic migraine , botulinum toxin , adverse effect , migraine disorders , intensive care medicine , anesthesia , psychiatry , pharmacology
Botulinum toxin type A (Botox) has been licensed for the prophylaxis of headaches in chronic migraine. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Anne MacGregor discusses its place in the treatment of migraine. Copyright © 2011 Wiley Interface Ltd